| This week's sponsor is CMIC Group. | |  | Partner with Japan’s Largest CRO for your global drug development
CMIC is the largest CRO in Japan, with extended services in drug development and GMP manufacturing, site management, regulatory consulting and contract sales. We have the full end to end solution to help you enter Japan market and fulfill your drug development and manufacturing needs in US, Japan and Asia. To learn more, click here. |
Today's Rundown Featured Story | | | Thursday, July 19, 2018 Gilead’s Kite Pharma has snagged an option to buy gamma delta T-cell receptor startup Gadeta. The deal sees Kite take a stake in Gadeta and commit to milestones tied to the progress of oncology candidates. |
|
|
Top Stories Thursday, July 19, 2018 Novartis is set to pay €95 million ($110 million) upfront for the global rights to Galapagos and MorphoSys’ anti-IL-17C antibody MOR106. The deal positions Novartis to take MOR106 forward in atopic dermatitis and other indications, handing over up to €850 million in milestones as it goes. Thursday, July 19, 2018 After a string of pipeline failures, Vical has called in advisers to help decide the future of the company. The move comes just over a month after Vical abandoned work on a genital herpes vaccine following a negative phase 2 trial. Thursday, July 19, 2018 Gritstone Oncology and Bristol-Myers Squibb will test the former's personalized neoantigen treatment in combination with the latter's Opdivo and Yervoy in patients with advanced solid tumors. Thursday, July 19, 2018 IFM Therapeutics is hiving off its NLRP3 stable into a subsidiary dubbed IFM Tre, which expects to advance its lead asset into phase 1 next year. Wednesday, July 18, 2018 A new startup from Johns Hopkins has launched with $36 million in financing, in the pursuit of disease-modifying agents for Parkinson’s disease and other neurodegenerative disorders. Thursday, July 19, 2018 Immunotherapy developer Aridis Pharmaceuticals has filed for a $34.5 million IPO as it plans to move its fully human antibodies for hospital-related infections into late-phase clinical trials. | This week's sponsor is ExL Events. | |  | |
Resources Sponsored by: Medidata Accelerate Clinical Research as Study Complexity Grows Sponsored by: Veeva See results from the Tufts eClinical Landscape Study – CRO Report on current data management practices, goals, and challenges for contract research organizations (CROs). Sponsored by: Docusign Life science companies are experiencing a significant transformation in how they bring new products to market. Sponsored by: Patheon, part of Thermo Fisher Scientific Biologics, orphan drugs, and precision medicine are on the rise, and that means some big changes for drug development and manufacturing companies. What should pharma companies look for when navigating this new era of small-volume manufacturing? Here are some ideas to consider when developing a new manufacturing strategy. |
|
